News and Comments

Biotech Firms with Guaranteed Growth Potential

  Thursday, July 07, 2016

Good news is not always great news that makes a difference. In the drug industry, clinical trial results that demonstrate a drug has fulfilled the requirements of the trials, including the primary and secondary endpoints does not always guarantee that the drug will be successful if and when it hits the market. Experience and follow up on certain firms enables us to see the real light at the end of the tunnel, not just celebrate reaching the end of it without knowing what to expect outside. This makes a big difference.  More...


  Monday, January 07, 2013

Using scientific skills towards building pipelines of promising products does not guarantee a happy ending for a small biotech firm. Pipelines’ breakthroughs need managements’ capabilities and swiftness of actions, which would walk them through the safest and fastest road towards approvals.  We believe Theravance (THRX) has benefited from both its scientists and management. The firm has come nearer than ever to reaching a happy beginning of substantial growth, or perhaps, a happy ending through acquisition, probably, by its partner GlaxoSmithKline (GSK).  More...

Recent Postings



Biocryst (BCRX) Jazz Pharmaceuticals (JAZZ) Abbott Laboratories (ABT) Valeant Pharmaceuticals International (VRX) Editas (EDIT) INNOVIVA (INVA) Ziofpharm (ZIOP) ARCA (ABIO) Array Pharmaceuticals (ARRY) ImmunoGen (IMGN) Sanofi-Aventis (SAN) Sarepta (SRPT) Global Cell Therapeutics (GBT) Spike Therapeutics (ONCE) Bellicum (BLCM) Cytokinetics (CYTK) Theravance (THRX) CRISPR Therapeutics (CRSP) MODERNA Dendreon (DNDN) Mirati Therapeutics (MRTX) Elan (ELN) KITE (KITE) GlaxoSmithKline (GSK) NOVOCURE (NVCR) Endometrial Cancer Roche (RHHBY) Aimmune Therapeutics (AIMT) Onyx (ONXX) Revlimid (lenolidamide) Agenus (AGEN) Benlysta (belimumab) Pluristem (PSTI) Trastuzumab-DM1 Idenix (IDIX) Anadys (ANDS) Tysabri REGULUS (RGLS) AERIE PHARMACEUTICALS Multiple Myeloma Ionis (IONS) Sequenom (SQNM) Alder Biopharmaceuticals (ALDR) HALOZYME (HALO) ZALTRAP™ Gilead (GILD) SYNTA (SNTA) Theravance Bio Pharma (TBPH) Intrexon (XON) TOKAI (TKAOI) C4 Therapeutics Illumina (ILMN) Intercept (ICPT) Sangamo (SGMO) Micromet (MITI) GUARDIAN HEALTH CompuGen (CGEN) Alnylam (ALNY) ABBVIE (ABBV) KERYX (KERX) Ridaforolimus Inovio (INO) Ocular Therapeutix (OCUL) Ariad (ARIA) Biogen Idec (BIIB) OSI (OSIP) Regeneron (REGN) RenenxBio (RGNX) AGOS (ARGS) Herceptin JUNO (JUNO) Auspex (ASPX) BIOMARIN (BMRN) Roche (ROCHE) ARGOS (ARGS) AstraZeneca (AZN) Human Longevity (HLI) Rapamune Seattle Genetics (SGEN) galapagos (GLPG) Genentech Dynavax (DVAX) Adaptimmune (ADAP) Human Genome Sciences (HGSI) Telaprevir Exelixis (EXEL) Sanofi (SNA) Velcade (bortezomib) SUNESIS PHARMACEUTICALS (SNSS) ADVENTRIX (ANX) SERES THERAPEUTICS (MCRB) Advaxis (ADXS) Xoma (XOMA) Galena (GALE) Merck (MRK) Prosensa (RNA) Anacor (ANAC) Bristol-Myers Squibb (BMY) PTC Therapeutics (PTCT) ACADIA (ACAD) Intermune (ITMN) Amgen (AMGN) IDERA (IDRA) Zerenex Prolor Biotech (PBTH) NEKTAR (NKTR)) VANDA (VNDA) Vitae Pharmaceuticals (VTAE) Vertex (VRTX) ISIS (ISIS) Sanofi (SNY) Agenus (AGEN Incyte (INCY) NANTKWEST (NK)